Fate Therapeutics, Inc. (FATE)

Fate Therapeutics Revenue

Fate Therapeutics had revenue of $1.30M in the quarter ending March 31, 2026, a decrease of -20.26%. This brings the company's revenue in the last twelve months to $6.32M, down -52.64% year-over-year. In the year 2025, Fate Therapeutics had annual revenue of $6.65M, down -51.24%.

• Revenue (ttm): $6.32M
• Revenue Growth: -52.64%
• P/S Ratio: 33.96
• Revenue / Employee: $39,230
• Employees: 161
• Market Cap: 214.47M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.65M	-6.99M	-51.24%
Dec 31, 2024	13.63M	-49.90M	-78.55%
Dec 31, 2023	63.53M	-32.77M	-34.03%
Dec 31, 2022	96.30M	40.45M	72.44%
Dec 31, 2021	55.85M	24.41M	77.66%
Dec 31, 2020	31.43M	20.75M	194.33%
Dec 31, 2019	10.68M	5.94M	125.32%
Dec 31, 2018	4.74M	634.00K	15.44%
Dec 31, 2017	4.11M	-296.00K	-6.72%
Dec 31, 2016	4.40M	1.97M	81.08%
Dec 31, 2015	2.43M	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	971.00K	-1.70M	-63.63%
Dec 31, 2012	2.67M	1.50M	128.21%
Dec 31, 2011	1.17M	-	-

Data Source: Fiscal.ai Last updated: May 13, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 19, 2026

Data Sources Report a data error